Cera ASD closure device long-term follow-up study
Part of Genetic & congenital, Heart & circulation clinical trials.
This study follows up with patients who already received the Cera ASD occluder device to close a hole in the heart (atrial septal defect). It looks at how well the device is working over time and checks for any late problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of hole in the heart called a secundum atrial septal defect (ASD).
- You were implanted with the Cera ASD Occluder between January 1, 2020 and December 31, 2023, following the device's instructions.
- You are willing to let the researchers collect and use your medical data, and you (or your legal representative) can sign a consent form.
- You do not have other complex heart problems that would need surgery to fix.
- You did not have a serious infection in the month before your implant, or any active infection that could not be treated before the procedure.
- You do not have a bleeding disorder, untreated ulcer, or other condition that prevents taking aspirin or another anti-platelet medicine for 6 months.
- You had no blood clots in your heart seen on an echocardiogram before the implant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that closes a common type of heart hole (atrial septal defect) and then dissolves over time. It may help reduce strain on the heart and improve symptoms without leaving a permanent implant.
This trial looks at whether a special 3D ultrasound picture helps doctors safely place a small device to close an atrial septal defect (ASD), a hole in the heart’s upper chambers. If you need ASD closure and are suitable for a device, the results could help improve guidance and outcomes.
This study uses a wearable ECG monitor to track heart rhythm before and after a procedure to close a hole in the heart. It aims to detect irregular heartbeats early, which may help prevent complications.
This trial tests a new way to close a hole in the heart (atrial septal defect) using only ultrasound pictures, without X-rays. It may help people who want to avoid radiation or cannot have X-ray-guided procedures.
This follow-up study monitors how well and how safely the Occlutech mVSD device works to close certain muscular heart “holes” (ventricular septal defects). You may join if you already had the device placed and can return for scheduled checkups to help doctors learn long-term outcomes.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
Hear when a new Atrial Septal Defect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.